Eletriptan hydrobromide monohydrate and pharmaceuticals thereof and their use as 5-HT1 receptor antagoists

摘要

Eletriptan hydrobromide monohydrate of formula as shown, may be used to treat diseases where the use a selective agonist of a 5-HT1 receptor is indicated such as migraine, hypertension, anxiety, eating disorders, obesity, drug abuse and pain. Also disclosed are processes for the production of eletriptan hydrobromide monohydrate.